tobago
you didn't respond to my other post
could you post a link to the nexavar better efficacy data
i cant seem to find it
all i can find is the nexavar not significant improvement data and bad side effects
not sure how nexavar will get around the pi-88 orphan drug market exclusivity in europe
can you advise
as i asked, how many have you got short
i think your $11.50 valuation might be a bit lo
69
tobagoyou didn't respond to my other postcould you post a link...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
